Gedea Biotech secures 1.3 MEuros (14 MSEK) to advance its antibiotic-free vaginal infection treatment pHyph towards market launch
Lund, Sweden, May 24, 2023: Gedea Biotech today announced that it has raised 1.3 MEuros (14 MSEK) for additional development activities of their product pHyph for antibiotic free treatment of vaginal infections. The funds will be used for: An ongoing proof-of-concept study for the treatment of…
Gedea Biotech initiates EpHect Clinical Trial for Antibiotic-free Treatment of Women with Vulvo Vaginal Candidiasis
Up to 75% of all women are affected by vaginal infection in their lifes Self-diagnoses leads often to unnecessary and inappropriate treatment use This study aims to confirm the safety and efficacy of pHyph in VVC Lund, Sweden, May 2, 2023. Gedea Biotech today announces that the treatment of the…